PubMed Health⌕ Search

Biomedical subjects

R W Wangenstein

Publications and source records attributed to R W Wangenstein.

2 recordsLinked to original sources

Genetic control of lipid transport in mice. II. Genes controlling structure of high density lipoproteins.

Genetic factors controlling the structure of high density lipoproteins (HDL) in mice have been examined. Surveys of inbred strains of mice revealed genetic structural variations of the two major apolipoproteins of mouse HDL, apolipoproteins A-I and A-II. The structural variations alter the charge of the proteins as judged by isoelectric focusing of HDL under denaturing conditions. The structural variations are inherited as single Mendelian genes exhibiting co-dominant expression. The structural gene for mouse apolipoprotein A-II, designated Alp-2, resides on mouse chromosome 1, tightly linked to Ly-m20, a lymphocyte alloantigen locus. Previous studies, as well as our results, suggest that the structural gene for mouse apolipoprotein A-I, designated Alp-1, is on mouse chromosome 9. The genetic structural variation for apo-A-I results in a shift in the charge of the entire family of apo-A-I isoforms, indicating that they are all encoded by a common structural gene. The structure of intact HDL, examined primarily by electrophoretic techniques, exhibits numerous and complex phenotypes among different strains of mice. One variation, controlling the density and possibly the size of HDL, has been studied in two sets of recombinant inbred strains of mice. The results indicate that the variation is controlled by a single major gene that is either tightly linked to or identical with the Alp-2 gene on chromosome 1. In addition to structural variation, inbred strains of mice exhibited considerable quantitative variation of plasma HDL. Thus, the mouse provides a useful model system for examining the genetic control of mammalian HDL structure and regulation.

Animals↗

Trans-acting temporal locus within the beta-glucuronidase gene complex.

Mice carrying the [Gus]H haplotype of the beta-glucuronidase gene complex have considerably decreased enzyme levels and a decreased rate of enzyme synthesis. This is now shown to result from the action of two regulatory loci within the gene complex. One is a systemic regulator, Gus-u, that acts cis to cause a uniform reduction in enzyme levels in all tissues. The other is a temporal locus, Gus-t, that acts trans to cause abrupt switches in the rate of enzyme synthesis in only certain tissues and at characteristic stages of development. The distinction between these two loci was made possible by the introduction of a method for quantitating the relative numbers of A and H allozyme subunits in beta-glucuronidase tetramers. The procedure involves purification of the enzyme, cleavage at methionyl residues with CNBr, isoelectric focusing to separate the peptides, and quantitation of the peptide containing the A/H amino acid substitution. The presence of a trans-acting regulatory locus within a gene complex raises evolutionary and functional questions about why it is located there and how it acts.

Aging↗